SBM — Sirona Biochem Balance Sheet
0.000.00%
Last trade - 00:00- CA$16.58m
- CA$18.82m
- CA$0.03m
Annual balance sheet for Sirona Biochem, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.73 | 1.54 | 0.778 | 0.422 | 0.571 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.457 | 0.496 | 0.443 | 0.797 | 0.444 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4.26 | 2.1 | 1.26 | 1.27 | 1.02 |
| Net Property, Plant And Equipment | — | 0.037 | 0.028 | 0.019 | 0.009 |
| Total Assets | 4.26 | 2.14 | 1.29 | 1.29 | 1.03 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.92 | 1.03 | 0.741 | 0.865 | 1.87 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.07 | 2.09 | 1.38 | 1.08 | 3.54 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2.19 | 0.047 | -0.097 | 0.215 | -2.51 |
| Total Liabilities & Shareholders' Equity | 4.26 | 2.14 | 1.29 | 1.29 | 1.03 |
| Total Common Shares Outstanding |